Director Vranesh Mark returned $1,400,316 worth of shares to the company (116,693 units at $12.00), closing all direct ownership in the company (SEC Form 4)
4 - SEMrush Holdings, Inc. (0001831840) (Issuer)
Live Feed
Delayed 3mPress · Analyst · Insider · Financials · Leadership Updates
Signed out · 3-min delay · Sign up for real-time
- Director Cantie Joseph S was granted 343 shares, increasing direct ownership by 1% to 23,818 units (SEC Form 4)
4 - TopBuild Corp (0001633931) (Issuer)
- Director Petrarca Mark A was granted 343 shares, increasing direct ownership by 2% to 15,068 units (SEC Form 4)
4 - TopBuild Corp (0001633931) (Issuer)
- Director Taylor Nancy M was granted 343 shares, increasing direct ownership by 6% to 6,431 units (SEC Form 4)
4 - TopBuild Corp (0001633931) (Issuer)
- Director Drake Deirdre was granted 343 shares, increasing direct ownership by 19% to 2,103 units (SEC Form 4)
4 - TopBuild Corp (0001633931) (Issuer)
- Director Donikowski Tina was granted 343 shares, increasing direct ownership by 9% to 4,123 units (SEC Form 4)
4 - TopBuild Corp (0001633931) (Issuer)
- Director Bautista Ernesto Iii was granted 343 shares, increasing direct ownership by 14% to 2,758 units (SEC Form 4)
4 - TopBuild Corp (0001633931) (Issuer)
- Director Covington Alec C was granted 343 shares, increasing direct ownership by 2% to 15,068 units (SEC Form 4)
4 - TopBuild Corp (0001633931) (Issuer)
- Ecopetrol announces the dates for the release of its first quarter 2026 earnings report and conference call
BOGOTA, Colombia, April 28, 2026 /PRNewswire/ -- Ecopetrol S.A ((BVC: ECOPETROL, NYSE:EC) hereby announces that on Tuesday, May 12, 2026, it will release its financial and operational results for the first quarter of 2026, after market closes. On Wednesday, May 13, 2026, the company's management will hold a virtual earnings conference call, with simultaneous webcasts in Spanish and English, at the following times:Conference Call 09:00 a.m. Colombia Time10:00 a.m. New York TimeTo participate in the conference call, please use the following link and select the preferred language f
- Director Conroy Kevin T was granted 2,286 units of Common shares without par value, increasing direct ownership by 2% to 133,737 units (SEC Form 4)
4 - ABBOTT LABORATORIES (0000001800) (Issuer)
- General Counsel & Secretary Lanzer David E. converted options into 33,299 shares and sold $1,181,232 worth of shares (33,299 units at $35.47) (SEC Form 4)
4 - Rexford Industrial Realty, Inc. (0001571283) (Issuer)
- Pershing Square Announces Pricing of the Combined IPO of Pershing Square USA and Pershing Square Inc.
Aggregate offering size of $5 billion Pershing Square USA, Ltd. ("PSUS"), an investment company managed by Pershing Square Capital Management, L.P. ("PSCM"), and Pershing Square Inc. ("PSI"), the parent company of PSCM, today announced the pricing of the combined initial public offering (the "PSUS IPO") of the common shares of beneficial interest of PSUS (the "PSUS Shares") and the initial public offering (the "PSI IPO", and together with the PSUS IPO, the "Combined IPO") of the common stock of PSI (the "PSI Shares"). The PSUS Shares and the PSI Shares are expected to begin trading on the New York Stock Exchange (NYSE) on April 29, 2026, under the symbol "PSUS" for the PSUS Shares and u
- EVP, CFO Balicka Julianna covered exercise/tax liability with 1,795 shares, decreasing direct ownership by 4% to 47,850 units (SEC Form 4)
4 - HOPE BANCORP INC (0001128361) (Issuer)
- New insider Conroy Kevin T claimed ownership of 131,451 units of Common shares without par value (SEC Form 3)
3 - ABBOTT LABORATORIES (0000001800) (Issuer)
- Chief Medical Officer Raben David exercised 5,500 shares at a strike of $3.79 and sold $125,830 worth of shares (5,500 units at $22.88) as part of a pre-agreed trading plan (SEC Form 4)
4 - Bicara Therapeutics Inc. (0002023658) (Issuer)
- SEC Form 4 filed by President Drafts William Arnold
4 - M-tron Industries, Inc. (0001902314) (Issuer)
- Sr. VP Chief Financial Officer Cunningham Sarah M was granted 11,840 shares and covered exercise/tax liability with 1,835 shares, increasing direct ownership by 31% to 42,430 units (SEC Form 4) (withholding obligation)
4 - Hamilton Beach Brands Holding Co (0001709164) (Issuer)
- Director Stratton John G was granted 2,286 units of Common shares without par value, increasing direct ownership by 12% to 21,319 units (SEC Form 4)
4 - ABBOTT LABORATORIES (0000001800) (Issuer)
- Oruka Therapeutics Announces Pricing of Upsized $700 Million Underwritten Public Offering
MENLO PARK, Calif., April 28, 2026 (GLOBE NEWSWIRE) -- Oruka Therapeutics, Inc. (NASDAQ:ORKA), a clinical-stage biopharmaceutical company focused on developing novel monoclonal antibody therapeutics for psoriasis and other inflammatory and immunology indications, today announced the pricing of its upsized underwritten public offering of 9,660,000 shares of its common stock at a price to the public of $72.50 per share. The gross proceeds to Oruka from this offering are expected to be approximately $700.4 million, before deducting underwriting discounts and commissions and other offering expenses and excluding any exercise of the underwriters' option to purchase additional shares. In additio